Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Lipoplasty device downclassification

This article was originally published in The Gray Sheet

Executive Summary

Final rule downclassifying suction lipoplasty systems for use in aesthetic body contouring from Class III to Class II published in the Feb. 17 Federal Register. The reclassification becomes effective March 19. FDA announced its intention to downclassify suction lipoplasty systems in November 1996 ("The Gray Sheet" Nov. 18, 1996, I&W-2). The agency issued the downclassification proposal based on findings in support of a 1989 recommendation by FDA's General and Plastic Surgery Devices Panel to downclassify the devices. The American Society for Aesthetic Plastic Surgery filed a petition in December 1988 requesting the downclassification...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT009626

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel